▶ 調査レポート

ポイントオブケア凝固試験装置の世界市場:市場規模、シェア、成長、動向、予測

• 英文タイトル:Point-of-Care Coagulation Testing Devices Market (Product: Instruments / Analyzers, Consumables and Accessories; Method: PT/INR, Viscoelastic Coagulation Monitoring, Others; End User: Hospitals, Diagnostic Laboratories, Clinics, Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019 - 2027

Transparency Market Researchが調査・発行した産業分析レポートです。ポイントオブケア凝固試験装置の世界市場:市場規模、シェア、成長、動向、予測 / Point-of-Care Coagulation Testing Devices Market (Product: Instruments / Analyzers, Consumables and Accessories; Method: PT/INR, Viscoelastic Coagulation Monitoring, Others; End User: Hospitals, Diagnostic Laboratories, Clinics, Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019 - 2027 / TPM-NV128資料のイメージです。• レポートコード:TPM-NV128
• 出版社/出版日:Transparency Market Research / 2019年11月8日
• レポート形態:英文、PDF、191ページ
• 納品方法:Eメール
• 産業分類:製薬
• 販売価格(消費税別)
  Single User¥625,860 (USD5,795)▷ お問い合わせ
  Multi User¥949,860 (USD8,795)▷ お問い合わせ
  Global Site License¥1,273,860 (USD11,795)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本資料は、ポイントオブケア凝固試験装置の世界市場について調べ、ポイントオブケア凝固試験装置の世界市場規模、市場動向、市場シェア、市場環境、市場予測、製品別(計器/分析装置、消耗品および付属品)分析、方法別(PT / INR、粘弾性凝固モニタリング、その他)分析、エンドユーザー別(病院、診断研究所、クリニック、その他)分析、関連企業情報などをまとめました。
・ポイントオブケア凝固試験装置の市場概要
・ポイントオブケア凝固試験装置の市場動向
・ポイントオブケア凝固試験装置の価格分析
・ポイントオブケア凝固試験装置の世界市場規模・予測
・ポイントオブケア凝固試験装置市場:製品別(計器/分析装置、消耗品および付属品)
・ポイントオブケア凝固試験装置市場:方法別(PT / INR、粘弾性凝固モニタリング、その他)
・ポイントオブケア凝固試験装置市場:方法別(PT / INR、粘弾性凝固モニタリング、その他)
・地域別分析(北米、ヨーロッパ、アジア太平洋、中東・アフリカ、南米)
・競争環境・関連企業分析

Healthcare companies in the point-of-care coagulation testing devices market are developing analyzers that meet the quality control standards laid down by central laboratories. They are increasing expertise in the development of POC (point-of-care) devices that generate timely results. With the surging trend of self-monitoring, patients can be assured of lab-accurate PT/INR (Prothrombin Time/International Normalized Ratio) results, with advancements in POC coagulation testing systems. As such, healthcare companies in the point-of-care coagulation testing devices market are developing mobile handheld devices that help improve outcomes and serve the convenience of patients who have undergone major surgeries.

Several advantages of POC coagulation testing are adding value for patients regarding hemostatic management, both, in and out of the hospital. Currently, manufacturers in the point-of-care coagulation testing devices landscape are creating the increased availability of POC devices for hospitals, since hospitals hold the highest revenue share amongst all the end-users in the landscape, with a value of ~US$ 500 million in 2018. Thus, during emergency cases in ICUs, coronary care units, and during surgeries, POC devices help provide immediate and actionable results to healthcare providers. As such, healthcare companies in the point-of-care coagulation testing devices market are tapping into incremental opportunities by expediting hemostasis management amongst patients in a range of settings, such as outpatient clinics, physician offices, pharmacies, and healthcare centres. For instance, in April 2018, Roche – a Swiss multinational healthcare company, announced the launch of CoaguChek® Vantus system, a self-testing device, enabled with the wireless reporting of INR results.

レポート目次

1. Preface

1.1. Market Definition and Scope

1.2. Market Segmentation

1.3. Key Research Objectives

1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary : Global Point-of-Care Coagulation Testing Devices

4. Market Overview

4.1. Introduction

4.1.1. Product Definition

4.1.2. Industry Evolution / Developments

4.2. Overview

4.3. Market Dynamics

4.3.1. Drivers

4.3.2. Restraints

4.3.3. Opportunities

4.4. Global Point-of-Care Coagulation Testing Devices Analysis and Forecasts, 2017–2027

4.4.1. Market Revenue Projections (US$ Mn)

4.5. Porter’s Five Forces Analysis

5. Key Insights

5.1. Key Events

5.2. Pricing Analysis

5.3. Technology Advancements

6. Global Point-of-Care Coagulation Testing Devices Analysis and Forecasts, by Product

6.1. Introduction & Definition

6.2. Key Findings / Developments

6.3. Global Point-of-Care Coagulation Testing Devices Market Revenue (US$ Mn) Forecast, by Product, 2017–2027

6.3.1. Instruments/Analyzers

6.3.2. Consumables and Accessories

6.4. Global Point-of-Care Coagulation Testing Devices Market Attractiveness, by Product

7. Global Point-of-Care Coagulation Testing Devices Analysis and Forecasts, by Method

7.1. Introduction & Definition

7.2. Key Findings / Developments

7.3. Global Point-of-Care Coagulation Testing Devices Market Revenue (US$ Mn) Forecast, by Method, 2017–2027

7.3.1. PT/INR

7.3.2. Others

7.3.3. Viscoelastic Coagulation Monitoring

7.4. Global Point-of-Care Coagulation Testing Devices Market Attractiveness, by Method

8. Global Point-of-Care Coagulation Testing Devices Analysis and Forecasts, by End-user

8.1. Introduction & Definition

8.2. Key Findings / Developments

8.3. Global Point-of-Care Coagulation Testing Devices Market Revenue (US$ Mn) Forecast, by End-user, 2017–2027

8.3.1. Hospitals

8.3.2. Diagnostic Laboratories

8.3.3. Clinics

8.3.4. Others

8.4. Global Point-of-Care Coagulation Testing Devices Market Attractiveness, by End-user

9. Global Point-of-Care Coagulation Testing Devices Analysis and Forecasts, by Region

9.1. Key Findings

9.2. Global Point-of-Care Coagulation Testing Devices Market Revenue (US$ Mn) Forecast, by Region

9.2.1. North America

9.2.2. Europe

9.2.3. Asia Pacific

9.2.4. Latin America

9.2.5. Middle East & Africa

9.3. Global Point-of-Care Coagulation Testing Devices Market Attractiveness by Region

10. North America Point-of-Care Coagulation Testing Devices Analysis and Forecast

10.1. Introduction

10.1.1. Key Findings

10.2. North America Point-of-Care Coagulation Testing Devices Market Revenue (US$ Mn) Forecast, by Product, 2017–2027

10.2.1. Instruments/Analyzers

10.2.2. Consumables and Accessories

10.3. North America Point-of-Care Coagulation Testing Devices Market Revenue (US$ Mn) Forecast, by Method, 2017–2027

10.3.1. PT/INR

10.3.2. Others

10.3.3. Viscoelastic Coagulation Monitoring

10.4. North America Point-of-Care Coagulation Testing Devices Market Revenue (US$ Mn) Forecast, by End-user, 2017–2027

10.4.1. Hospitals

10.4.2. Diagnostic Laboratories

10.4.3. Clinics

10.4.4. Others

10.5. North America Point-of-Care Coagulation Testing Devices Market Revenue (US$ Mn) Forecast, by Country, 2017–2027

10.5.1. U.S.

10.5.2. Canada

10.6. North America Point-of-Care Coagulation Testing Devices Market Attractiveness Analysis

10.6.1. By Product

10.6.2. By Method

10.6.3. By End-user

10.6.4. By Country

11. Europe Point-of-Care Coagulation Testing Devices Analysis and Forecast

11.1. Introduction

11.1.1. Key Findings

11.2. Europe Point-of-Care Coagulation Testing Devices Market Revenue (US$ Mn) Forecast, by Product, 2017–2027

11.2.1. Instruments/Analyzers

11.2.2. Consumables and Accessories

11.3. Europe Point-of-Care Coagulation Testing Devices Market Revenue (US$ Mn) Forecast, by Method, 2017–2027

11.3.1. PT/INR

11.3.2. Others

11.3.3. Viscoelastic Coagulation Monitoring

11.4. Europe Point-of-Care Coagulation Testing Devices Market Revenue (US$ Mn) Forecast, by End-user, 2017–2027

11.4.1. Hospitals

11.4.2. Diagnostic Laboratories

11.4.3. Clinics

11.4.4. Others

11.5. Europe Point-of-Care Coagulation Testing Devices Market Revenue (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

11.5.1. Germany

11.5.2. U.K.

11.5.3. France

11.5.4. Spain

11.5.5. Italy

11.5.6. Rest of Europe

11.6. Europe Point-of-Care Coagulation Testing Devices Market Attractiveness Analysis

11.6.1. By Product

11.6.2. By Method

11.6.3. By End-user

11.6.4. By Country/Sub-region

12. Asia Pacific Point-of-Care Coagulation Testing Devices Analysis and Forecast

12.1. Introduction

12.1.1. Key Findings

12.2. Asia Pacific Point-of-Care Coagulation Testing Devices Market Revenue (US$ Mn) Forecast, by Product, 2017–2027

12.2.1. Instruments/Analyzers

12.2.2. Consumables and Accessories

12.3. Asia Pacific Point-of-Care Coagulation Testing Devices Market Revenue (US$ Mn) Forecast, by Method, 2017–2027

12.3.1. PT/INR

12.3.2. Others

12.3.3. Viscoelastic Coagulation Monitoring

12.4. Asia Pacific Point-of-Care Coagulation Testing Devices Market Revenue (US$ Mn) Forecast, by End-user, 2017–2027

12.4.1. Hospitals

12.4.2. Diagnostic Laboratories

12.4.3. Clinics

12.4.4. Others

12.5. Asia Pacific Point-of-Care Coagulation Testing Devices Market Revenue (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

12.5.1. China

12.5.2. Japan

12.5.3. India

12.5.4. Australia & New Zealand

12.5.5. Rest of Asia Pacific

12.6. Asia Pacific Point-of-Care Coagulation Testing Devices Market Attractiveness Analysis

12.6.1. By Product

12.6.2. By Method

12.6.3. By End-user

12.6.4. By Country/Sub-region

13. Latin America Point-of-Care Coagulation Testing Devices Analysis and Forecast

13.1. Introduction

13.1.1. Key Findings

13.2. Latin America Point-of-Care Coagulation Testing Devices Market Revenue (US$ Mn) Forecast, by Product, 2017–2027

13.2.1. Instruments/Analyzers

13.2.2. Consumables and Accessories

13.3. Latin America Point-of-Care Coagulation Testing Devices Market Revenue (US$ Mn) Forecast, by Method, 2017–2027

13.3.1. PT/INR

13.3.2. Others

13.3.3. Viscoelastic Coagulation Monitoring

13.4. Latin America Point-of-Care Coagulation Testing Devices Market Revenue (US$ Mn) Forecast, by End-user, 2017–2027

13.4.1. Hospitals

13.4.2. Diagnostic Laboratories

13.4.3. Clinics

13.4.4. Others

13.5. Latin America Point-of-Care Coagulation Testing Devices Market Revenue (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

13.5.1. Brazil

13.5.2. Mexico

13.5.3. Rest of Latin America

13.6. Latin America Point-of-Care Coagulation Testing Devices Market Attractiveness Analysis

13.6.1. By Product

13.6.2. By Method

13.6.3. By End-user

13.6.4. By Country/Sub-region

14. Middle East & Africa Point-of-Care Coagulation Testing Devices Analysis and Forecast

14.1. Introduction

14.1.1. Key Findings

14.2. Middle East & Africa Point-of-Care Coagulation Testing Devices Market Revenue (US$ Mn) Forecast, by Product, 2017–2027

14.2.1. Instruments/Analyzers

14.2.2. Consumables and Accessories

14.3. Middle East & Africa Point-of-Care Coagulation Testing Devices Market Revenue (US$ Mn) Forecast, by Method, 2017–2027

14.3.1. PT/INR

14.3.2. Others

14.3.3. Viscoelastic Coagulation Monitoring

14.4. Middle East & Africa Point-of-Care Coagulation Testing Devices Market Revenue (US$ Mn) Forecast, by End-user, 2017–2027

14.4.1. Hospitals

14.4.2. Diagnostic Laboratories

14.4.3. Clinics

14.4.4. Others

14.5. Middle East & Africa Point-of-Care Coagulation Testing Devices Market Revenue (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

14.5.1. GCC

14.5.2. South Africa

14.5.3. Rest of Middle East & Africa

14.6. Middle East & Africa Point-of-Care Coagulation Testing Devices Market Attractiveness Analysis

14.6.1. By Product

14.6.2. By Method

14.6.3. By End-user

14.6.4. By Country/Sub-region

15. Competitive Landscape

15.1. Market Player – Competition Matrix (By Tier and Size of companies)

15.2. Market Rank Analysis by Company (2018)

15.3. Competitive Business Strategies

15.4. Company Profiles

15.4.1. F. Hoffmann-La Roche AG

15.4.1.1. Company Overview (HQ, Business Segments, Employee Strength)

15.4.1.2. Company Financials

15.4.1.3. Growth Strategies

15.4.1.4. SWOT Analysis

15.4.2. Abbott Laboratories

15.4.2.1. Company Overview (HQ, Business Segments, Employee Strength)

15.4.2.2. Company Financials

15.4.2.3. Growth Strategies

15.4.2.4. SWOT Analysis

15.4.3. Siemens Healthineers

15.4.3.1. Company Overview (HQ, Business Segments, Employee Strength)

15.4.3.2. Company Financials

15.4.3.3. Growth Strategies

15.4.3.4. SWOT Analysis

15.4.4. Medtronic plc

15.4.4.1. Company Overview (HQ, Business Segments, Employee Strength)

15.4.4.2. Company Financials

15.4.4.3. Growth Strategies

15.4.4.4. SWOT Analysis

15.4.5. Haemonetics Corporation

15.4.5.1. Company Overview (HQ, Business Segments, Employee Strength)

15.4.5.2. Company Financials

15.4.5.3. Growth Strategies

15.4.5.4. SWOT Analysis

15.4.6. HemoSonics, LLC

15.4.6.1. Company Overview (HQ, Business Segments, Employee Strength)

15.4.6.2. Growth Strategies

15.4.6.3. SWOT Analysis

15.4.7. Micropoint Bioscience, Inc.

15.4.7.1. Company Overview (HQ, Business Segments, Employee Strength)

15.4.7.2. Growth Strategies

15.4.7.3. SWOT Analysis

15.4.8. Werfen

15.4.8.1. Company Overview (HQ, Business Segments, Employee Strength)

15.4.8.2. Company Financials

15.4.8.3. Growth Strategies

15.4.8.4. SWOT Analysis

15.4.9. Sienco, Inc.

15.4.9.1. Company Overview (HQ, Business Segments, Employee Strength)

15.4.9.2. Growth Strategies

15.4.9.3. SWOT Analysis

15.4.10. Koninklijke Philips N.V.

15.4.10.1. Company Overview (HQ, Business Segments, Employee Strength)

15.4.10.2. Company Financials

15.4.10.3. Growth Strategies

15.4.10.4. SWOT Analysis